title: Rosiglitazone and the risk of adverse cardiovascular outcomes.
authors: Pharmaceutical Outcomes and Policy, College of Pharmacy and Epidemiology, Colleges of Public Health and Health Professions and Medicine, University of Florida, Gainesville, Florida, USA. almut@ufl.edu
authors: A G
authors: AG
authors: Winterstein